verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 240 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-4582
Product ID 50090-4582_b77b1f0e-f256-4aaf-8126-70a24ed32fd4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206173
Listing Expiration 2026-12-31
Marketing Start 2019-05-15

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500904582
Hyphenated Format 50090-4582

Supplemental Identifiers

RxCUI
897649
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA206173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 240 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-4582-0)
  • 90 TABLET in 1 BOTTLE (50090-4582-4)
source: ndc

Packages (2)

50090-4582-0 30 TABLET in 1 BOTTLE (50090-4582-0) 50090-4582-4 90 TABLET in 1 BOTTLE (50090-4582-4)

Ingredients (1)

verapamil hydrochloride (240 mg/1)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b77b1f0e-f256-4aaf-8126-70a24ed32fd4", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["ed182ebe-8299-4680-9dea-ef79d30db683"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-4582-0)", "package_ndc": "50090-4582-0", "marketing_start_date": "20191004"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-4582-4)", "package_ndc": "50090-4582-4", "marketing_start_date": "20191004"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "50090-4582_b77b1f0e-f256-4aaf-8126-70a24ed32fd4", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50090-4582", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}